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ABSTRACT
Objectives To examine the prospective associations
between body mass index (BMI), waist circumference,
and fat mass in childhood and cardiovascular risk factors
at age 15-16.
Design Prospective cohort study.
Setting Avon Longitudinal Study of Parents and Children.
Participants 5235 children aged 9-12 at start of study.
Main exposures BMI, waist circumference, and fat mass
determined by dual energy x ray absorptiometry,
assessed at age 9-12 and at age 15-16.
Main outcome measures Systolic and diastolic blood
pressure and concentrations of fasting glucose, insulin,
triglycerides, low density lipoprotein cholesterol, and
high density lipoprotein cholesterol assessed at age 15-
16.
Results In girls a 1 SD greater BMI at age 9-12 was
associatedwith cardiovascular risk factors at age 15-16 in
fully adjusted models: odds ratio 1.23 (95% confidence
interval 1.10 to 1.38) for high systolic blood pressure
(≥130 mm Hg); 1.19 (1.03 to 1.38) for high concentration
of low density lipoprotein cholesterol (≥2.79 mmol/l);
1.43 (1.06 to 1.92) for high concentration of triglycerides
(≥1.7 mmol/l); 1.25 (1.08 to 1.46) for low concentration
of high density lipoprotein cholesterol (<1.03 mmol/l);
and 1.45 (1.22 to 1.73) for high concentration of insulin
(≥16.95 IU/l). Equivalent results in boys were 1.24 (1.13
to 1.37) for systolic bloodpressure; 1.30 (1.07 to 1.59) for
lowdensity lipoprotein cholesterol; 1.96 (1.51 to2.55) for
triglycerides; 1.39 (1.22 to 1.57) for high density
lipoprotein cholesterol, and 1.84 (1.56 to 2.17) for
insulin. BMI was associated with high fasting glucose
(≥5.6mmol/l) only in boys (1.18, 1.03 to 1.36).With these
binary outcomes there was statistical evidence that
associations differed between girls and boys for fasting
glucose (P=0.03) and insulin (P<0.001). When risk factors
were examined as continuous outcomes there was
evidence for stronger associations of BMI with more
adverse levels in boys than girls for fasting insulin,
glucose, and triglyceride concentrations (all interaction
P≤0.03). BMI, waist circumference, and fat mass were all
strongly correlated with each other (r=0.89-0.94), and
associations of the three with cardiovascular outcomes
were of similar magnitude with statistical evidence of
consistency in associations (all P>0.2 for heterogeneity).
Whenwaist circumference or fat mass or both were added
to models including BMI they did not increase the
variation in cardiovascular risk factors already explained
by BMI and confounders alone. Girls who were
overweight/obese at age 9-12 but were normal weight by
15-16 had similar odds of adverse levels of risk factors to
those who were normal weight at both ages. In boys odds
of high systolic blood pressure, high concentrations of
triglycerides and insulin, and low concentrations of high
density lipoprotein cholesterol remained higher in this
group compared with those who were normal weight at
both ages but were lower than in those who remained
overweight/obese at both ages.
ConclusionsMeasurements of waist circumference or
directly assessed fatmass in childhood do not seem to be
associated with cardiovascular risk factors in
adolescence any more strongly than BMI. Girls who
favourably alter their overweight status between
childhood and adolescence have cardiovascular risk
profiles broadly similar to those who were normal weight
at both time points, but boyswho change fromoverweight
to normal show risk factor profiles intermediate between
those seen in boys who are normal weight at both ages or
overweight at both ages.
INTRODUCTION
Higher bodymass index (BMI) in childhoodor adoles-
cence is associated with an increased risk of cardio-
vascular disease in later life, with this association
being linear across most of the BMI distribution.1-3
Childhood BMI is also associated with cardiovascular
risk factors, carotid intima media thickness, and left
ventricular mass in early or mid-adulthood.4-8 Several
cross sectional studies have shown associations
between measurements of childhood adiposity, most
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commonly BMI, and cardiovascular risk factors.9-12
These associations, however, have rarely been
explored prospectively, and previous studies have
not compared different measurements of adiposity
and its distribution. BMI has been criticised as an
inadequate measure of adiposity, particularly in chil-
dren, in whom annual increases in BMI can reflect
increases in lean mass more so than fat mass,13 14 but
it is unknown whether more direct measurement of
fat, or its distribution, can predict cardiovascular risk
factors more strongly than BMI in children.12
We determined the association between BMI, waist
circumference, and directly assessed fat mass assessed
at age 9-12, and the change in these between 9-12 and
15-16, with cardiovascular risk factors assessed at age
15-16. We compared the magnitudes of association
between the three measurements of adiposity to deter-
mine whether either a direct measure of fat mass or a
measure of central adiposity distribution (waist cir-
cumference) was more strongly associated than BMI
with cardiovascular risk factors.
METHODS
We used data from the Avon Longitudinal Study of
Parents and Children (ALSPAC), a longitudinal popu-
lation based birth cohort that recruited 14 541 preg-
nant women with expected delivery dates from 1
April 1991 to 31 December 1992 (www.alspac.bris.
ac.uk).15 Since age 7 surviving offspring have been
invited to regular follow-up clinics. In the current ana-
lysis we examined data from three clinics conducted
when the children were aged 9-10, 11-12, and 15-16.
Each clinic used the same protocols for assessing
adiposity. Current age of the child was recorded in
months. Weight and height were measured with the
child in light clothing and without shoes. Weight was
measured to the nearest 0.1 kg with Tanita scales and
height to the nearest 0.1cm with a Harpenden stadi-
ometer. A flexible tape was used to measure waist cir-
cumference to the nearest 1 mm at the mid-point
between the lower ribs and the pelvic bone. A Lunar
Prodigy narrow fan beam densitometer was used to
performwhole body dual energy x ray absorptiometry
tomeasure lean and fatmass. For ourmain analyseswe
used sex, age (in month categories), and standard
deviation scores (z scores) of BMI, waist circumfer-
ence, and fat mass to compare the magnitudes of their
associations. As in a previous study16 we used baseline
adiposity data for these analyses by combining data
from either the 9-10 or 11-12 clinic, using the
9-10 year assessment for all who had these measure-
ments and the 11-12 year assessments for those who
did not.
Blood pressure (at all clinics) was measured with a
Dinamap 9301 Vital Signs Monitor (Morton Medical,
London) with the correct cuff size. Two readings of
systolic and diastolic blood pressure were recorded,
with the child at rest and their arm supported, and we
used the mean of the two measures.
At the 15-16 year clinic participants were asked to
fast overnight for those attending in the morning or
for a minimum of six hours for those attending after
lunch. Blood samples were immediately spun and fro-
zen at −80oC. Measurements were assayed three to
nine months after samples were taken, with no pre-
vious freeze-thaw cycles. Plasma lipid concentrations
(total cholesterol, triglycerides, and high density lipo-
protein cholesterol) were measured bymodification of
the standard Lipid Research Clinics Protocol by using
enzymatic reagents for lipid determination. Low den-
sity lipoprotein cholesterol concentration was deter-
mined from these with the Friedwald equation (low
density lipoprotein cholesterol=total cholesterol
−(high density lipoprotein cholesterol+triglycer-
ides×0.45)). Insulin was measured with an enzyme
linked immunosorbent assay (ELISA) (Mercodia,
Uppsala, Sweden) that does not cross-react with proin-
sulin, and plasma glucose was measured with an auto-
mated assay.
Potential confounding factors considered included
maternal age at birth of the child, parity, household
occupational social class, parental education, birth
weight, height, gestational age, parental BMI, age of
the child (at the time of assessment of BMI, waist cir-
cumference, or fat mass), and pubertal status (assessed
by parental report at baseline with Tanner question-
naires and whether girls had gone through menarche
and by self report at outcome with the same instru-
ments). All results are presented separately for girls
and boys and therefore sex is not considered a con-
founder. Full details of how these variables were
assessed are provided in the supplementary material
on bmj.com.
Statistical analysis
All analyses were conducted in Stata/MP 11.0. Corre-
lations between all anthropometric measurements
were assessed with Pearson’s correlation coefficient
by using the anthropometric measurements on their
original scale (that is, not as SD scores). Repeating
these with age and sex standardised z scores did not
change the results nor did additional adjustment (par-
tial correlation coefficients) for age and sex (data avail-
able from authors on request).
Because there was evidence of sex differences in
some of the main associations, we have presented all
regression results separately by sex andP values for the
null hypothesis of no difference in association between
girls and boys (exposure-sex interaction).
Dealing with missing data
Over the study, 7725, 7159, and 5509 participants
attended the 9-10 year, 11-12 year, and 15-16 year
clinics, respectively. Our eligible study sample included
anychildwhoattendedeither the9-10yearor11-12year
clinic (n=8362) and also attended the 15-16 year clinic;
5235 individuals fulfilled these criteria.
To increase efficiency and minimise selection bias
we used multivariate multiple imputation to impute
missing variables for participants considered to be eli-
gible (that is, those attending one or other of the 9-10 or
11-12 year assessment and also the 15-16 year
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assessment), including all exposures, covariables, out-
comes, and potential predictors of missing data in the
imputation equations.17 Full details of this procedure
are provided in the supplementary material on
bmj.com. Tables B (girls) and C (boys) on bmj.com
compare the distributions of imputed variables in the
imputed datasets and the observed data (with no impu-
tation) and show that distributions in imputed datasets
were similar to those observed, providing some evi-
dence that the missing data were missing at random
(an assumption of this imputation procedure). We
also repeated all analyses including only those with
complete data on all variables used in any analyses—
that is, without imputation (n=1785).
Prospective associations of adiposity with cardiovascular
risk factors
To provide clinical insights for our main analyses we
examined associations with each risk factor as a binary
outcome, comparing those who had levels above (or
below for high density lipoprotein cholesterol) a
threshold that indicates increased risk in this age
group. The international diabetes federation provides
thresholds for defining children/adolescents at risk of
future cardiovascular disease for triglycerides, high
density lipoprotein cholesterol, glucose, and blood
pressure in the age group 10-<16 and states that adult
thresholds should be used in those aged ≥16.18 The
mean (SD) age of participants at assessment of risk fac-
tors in our study was 15.5 (0.3), and 91% were under
16. We therefore applied the international diabetes
federation thresholds to all participants, and in a sensi-
tivity analysis repeated analyses with those aged ≥16
(9%) assigned high risk if they had values above adult
thresholds. The results from this sensitivity analysis
(including the prevalence to 1 decimal place of those
at risk) did not differ from the results of analyses that
used the childhood/adolescent thresholds for all parti-
cipants, and we present only results using the child/
adolescent thresholds. For low density lipoprotein
cholesterol and insulin the international diabetes fed-
eration does not provide childhood/adolescent thresh-
olds, and even in adults there is no agreed threshold of
hyperinsulinaemia. For these two risk factors we used
those who had values equal to or over the 90th centile
in our cohort to indicate being at risk. Thresholds used
to indicate future increased risk of cardiovascular dis-
ease for each risk factor were ≥130 mmHg for systolic
blood pressure, ≥85 mm Hg for diastolic blood pres-
sure, ≥1.7 mmol/l for triglycerides, <1.03 mmol/l for
high density lipoprotein cholesterol; ≥2.79 mmol/l for
low density lipoprotein cholesterol, ≥5.6 mmol/l for
glucose, and ≥16.95 IU/l for insulin.
We also examined associations with risk factors as
continuous outcomes. Fasting insulin and triglyceride
concentrations were positively skewed, and therefore
we used log values in regression analyses; distributions
of insulin and triglyceride and of the residuals in the
regression models were normal with these transfor-
mations. The results from the regression analyses
with log insulin and triglyceride concentration were
exponentiated to give ratios of geometric means per
SD (z scores) change in adiposity. A ratio of geometric
means is a proportionate differencewith a null value of
1. For example, a ratio of geometric means of 1.10 sug-
gests a 10% difference between exposure groups or
levels in the outcome.
We used multivariable logistic regression (for binary
outcomes) and linear regression (for the risk factors as
continuous outcomes) to examine associations of each
of the adiposity measurements with the cardiovascular
risk factors.Weadjusted for age inmonths at the timeof
assessment of adiposity in all models. We also adjusted
for height and height2 for all adipositymarkers because
at age 9-12 all of these measurements, including BMI,
were positively associated with height. The fully
adjusted model additionally controlled for maternal
age at birth of the child, parity, household occupational
social class, parental education, birth weight, gesta-
tional age, parental BMI, and pubertal status.
Examining linear v threshold associations
Weused twomethods to examinewhether associations
were linear across the distribution of adiposity risk fac-
tors or driven primarily by increased risk only in those
at the upper end of the distribution of adiposity. Firstly,
we split the exposure into fifths, plotted mean levels of
risk factors across these fifths, and looked at these
graphs to see if therewas any clear evidence of a thresh-
old effect.We ran regressionmodels with these fifths as
four indicator variables (non-linear) and compared this
model with one in which the fifths were included as a
single variable (a score from 1 to 5; linearmodel across
fifths). We used a likelihood ratio test for the compar-
ison between these twomodels. Secondly, we repeated
multivariable analyses in children defined as normal
weight (that is, excluding overweight/obese based on
sex and age specific cut points for BMI from the Inter-
national Obesity Task Force (IOTF)19 (see table D on
bmj.com for the cut points used).
Change in adiposity and risk factors for cardiovascular disease
We examined the association of change in adiposity
between9-12 years and 15-16years and cardiovascular
risk factors assessed at 15-16 years in two ways. Firstly,
we used a continuous variable of the adiposity z scores
at age 15-16 minus the z scores at age 9-12. We
included that as the main exposure variable in regres-
sion models and additionally adjusted for baseline
(9-12 years) adiposity. Secondly, we examined associa-
tions of change in categories of overweight/obesity sta-
tus between age 9-12 and 15-16 with cardiovascular
risk factors. For BMI overweight/obesity was defined
according to criteria from the International Obesity
Task Force19; for waist circumference, central over-
weight/obesity was defined as being at ot above the
90th centile,18 with age and sex specific centile curves
derived for British children/adolescents20; for fat mass
(in the absence of any guidance or national age and sex
specific growth curves) we defined those above the
90th centile for age and sex in our cohort as being over-
weight/obese.
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Heterogeneity in associations between different
measurements of adiposity
Because the estimates from models with each of the
three adiposity measurements are not from indepen-
dent studies (they are all from the same cohort) it
would not be appropriate to use standard tests of
heterogeneity (such as I2 or a Q statistic) used in
meta-analyses. Therefore, we used 1000 bootstrap
replications21 to estimate standard errors of differences
between log odds (for binary outcomes) and between
means (for continuouslymeasured outcomes) between
models (for example, between the associations of BMI
with systolic blood pressure and waist circumference
and systolic blood pressure). We calculated P values
from these standard errors based on a normal approx-
imation for the sampling distribution of the log odds
ratios/mean differences, after checking the bootstrap
distributions were close to normal using normal prob-
ability plots (all were). These P values provide a test of
heterogeneity between the estimates with different
measurements of adiposity.
Ourmain interest herewas to determinewhether the
magnitude of association between BMI and cardio-
vascular risk was as strong as that between more
directly assessed fat mass and centrally distributed fat
and these outcomes. The appropriate way to address
this is to examine associations with each exposure
separately and then compare the resulting regression
coefficients as described above. If the magnitudes of
association are similar this suggests that use of BMI in
routine clinical practice and public health surveillance
is valuable andwill not importantly underestimate risk.
Two related questions are whether adding other mea-
surements of adiposity to a model with BMI already
included will increase the ability to predict risk com-
pared with BMI alone and whether when all three are
included in amodel together there is evidence that they
are all independently (of each other) related to out-
comes. We have not addressed these questions in
great detail here as we feel to do so requires consider-
ably more space. Furthermore, the strong correlations
between all three adiposity measurements (see below)
makes inclusion of two or all three of them in the same
regression model potentially problematic because of
colinearity. We have done one final set of analyses in
which we compare the percentage of variation in the
outcome explained by exposure variables in combina-
tion from a series of regression models (using 100×R2)
with outcomes as continuous variables. The series of
regressionmodels thatwe comparedwere: all potential
confounders but none of the adiposity measures; all
potential confounders and BMI; all potential confoun-
ders, BMI, and waist circumference; all potential con-
founders, BMI, and fat mass; and all potential
confounders, BMI, waist circumference, and fat mass.
We also determined the variance inflation factor (a
measure of colinearity) for each adiposity measure in
all but the firstmodel; variance inflation factors over 10
are considered to introduce problems of colinearity.22
RESULTS
The characteristics of the cohort are shown in table E
on bmj.com. According to International Obesity Task
Force (IOTF) criteria, at baseline (age 9-12) 18.5%
(965) of the participants were overweight and 4.5%
(234) were obese. The prevalence of cardiovascular
risk factors at age 15-16 varied between 2.9% for high
diastolic blood pressure (144) and triglyceride concen-
trations (95) to 28.8% (1421) for high systolic blood
pressure. Table F on bmj.com shows the correlations
between parental and childhood anthropometric mea-
surements; correlations were similar in girls and boys
(all P>0.5 for interaction) and therefore results were
combined. At each of the three ages all three of the
measurements of adiposity were strongly correlated
with each other (r=0.89-0.94), and each measurement
of adiposity was strongly positively correlated with the
same measurement at different ages (r=0.63-0.93).
Table G on bmj.com shows the cross sectional asso-
ciations of BMI, waist circumference, and fat mass
assessed at age 15-16 with the cardiovascular risk fac-
tors treated as binary outcomes, and table H on
bmj.com shows the same cross sectional associations
with outcomes as continuous variables, for all eligible
participants withmissing data imputed. See the appen-
dix on bmj.com for a full discussion of these results.
Table 1 shows the prospective associations of child-
hood (9-12 years) BMI, waist circumference, and fat
mass with cardiovascular risk factors (as binary vari-
ables) at age 15-16 years. In girls and boys all three
adiposity measures were associated with increased
odds of adverse levels of systolic blood pressure and
adverse concentrations of fasting low density lipopro-
tein cholesterol, triglycerides, high density lipoprotein
cholesterol, and insulin. In boys only they were also
associatedwith increased odds of high glucose concen-
tration. Adiposity measures were not associated with
high diastolic blood pressure in either sex. Adjustment
for potential confounding factors did not substantively
alter associations. The pattern of associations were
similarwithoutcomeson thecontinuous scale (table 2).
With outcomes assessed as binary or continuous mea-
surements there was statistical evidence for sex inter-
actions (stronger associations in boys than in girls) for
fasting insulin, and, additionally, when assessed on the
continuous scale there was evidence of a stronger asso-
ciation in boys than girls for fasting glucose and trigly-
cerides for all three measures of adiposity. There was
statistical evidence that associations were consistent
with each other whether BMI, waist circumference,
or fat mass was used (all P≥0.2 for heterogeneity from
bootstrap analyses).
When we restricted analysis to children who were
normal weight, all associations were similar to those
presented (results available from authors), suggesting
that they were not driven solely by a threshold effect of
increased risk in those at the upper end of the distribu-
tion.When associations existed theywere linear across
the distribution of values (all P<0.001 for linear trend),
with no evidence of threshold effects with marked
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increases in risk in those at the upper end of the distri-
bution (see figs 1a-1j on bmj.com).
Table 3 shows the association of change in adiposity
z scores between 9-12 years and 15-16 years with ado-
lescent cardiovascular risk factors as binary outcomes
at age 15-16. In both sexes a greater increase in adip-
osity SD score between the two ages was associated
with increased odds of adverse levels of systolic
blood pressure and adverse concentrations of fasting
low density lipoprotein cholesterol, triglycerides,
high density lipoprotein cholesterol, and insulin for
all three measures of adiposity. In boys only a greater
increase in adiposity z scores between these ages was
also associated with an increased odds of high glucose
concentrations.
Table 4 shows the association between change in
overweight/obesity status according to the Inter-
national Obesity Task Force and risk factors as binary
outcomes. Consistent with results in tables 1-3 there
were no associations between these categories and dia-
stolic blood pressure (data not shown). Girls who were
overweight/obese at age 9-12 but were normal weight
by 15-16 had similar odds of adverse levels of risk fac-
tors to those who were normal weight at both ages. In
boys odds of high systolic bloodpressure, high concen-
trations of triglycerides and insulin, and low concentra-
tions of high density lipoprotein cholesterol remained
higher in this group than in those who were normal
weight at both ages, but were lower than in those who
remained overweight/obese at both ages or who were
normal at age 9-12 and then overweight/obese at age
15-16.
Tables I and J onbmj.comshowcharacteristics of the
cohort by categories of overweight/obesity. In both
boys and girls, those who were overweight/obese at
age 9-12 but normal weight by 15-16 had lower mean
BMI, waist circumference, and fat mass at the 9-10 and
11-12 assessments than those who were overweight/
obese at age 9-12 and remained in this category at 15-
16. By contrastmean systolic bloodpressure at the 9-10
and 11-12 assessments was similar in those who chan-
ged from overweight/obese to normal compared with
those who remained overweight/obese at both ages. In
terms of parental characteristics that might distinguish
the children who were overweight/obese at 9-12 but
became normal weight by 15-16 from those who
remained overweight/obese at both ages, mother’s
BMI before pregnancy was on average lower, they
Table 1 | Prospective associations between BMI, waist, and fat mass (assessed at age 9-12) and cardiovascular risk factors
as binary outcomes at age 15-16 in all eligible participants with missing data imputed by multivariate multiple imputation
(n=5235). Figures are odds ratios of outcome per 1SD (z score) of exposure (95% confidence interval)
Exposure and outcome*
Girls (n=2747) Boys (n=2488) P value for sex
interaction§Model 1† Model 2‡ Model 1† Model 2‡
BMI
High systolic BP 1.24 (1.13 to 1.37) 1.23 (1.10 to 1.38) 1.26 (1.15 to 1.37) 1.24 (1.13 to 1.37) 0.91
High diastolic BP 1.05 (0.79 to 1.39) 1.11 (0.81 to 1.52) 1.01 (0.82 to 1.25) 1.06 (0.84 to 1.35) 0.37
High LDLc 1.24 (1.09 to 1.40) 1.19 (1.03 to 1.38) 1.33 (1.11 to 1.59) 1.30 (1.07 to 1.59) 0.10
High triglycerides 1.35 (1.02 to 1.78) 1.43 (1.06 to 1.92) 1.93 (1.54 to 2.41) 1.96 (1.51 to 2.55) 0.49
Low HDLc 1.37 (1.20 to 1.57) 1.25 (1.08 to 1.46) 1.43 (1.27 to 1.61) 1.39 (1.22 to 1.57) 0.24
High glucose 1.06 (0.87 to 1.29) 1.03 (0.84 to 1.27) 1.22 (1.07 to 1.38) 1.18 (1.03 to 1.36) 0.03
High insulin 1.53 (1.31 to 1.79) 1.45 (1.22 to 1.73) 1.88 (1.63 to 2.16) 1.84 (1.56 to 2.17) <0.001
Waist circumference
High systolic BP 1.21 (1.09 to 1.35) 1.18 (1.05 to 1.33) 1.24 (1.12 to 1.36) 1.20 (1.08 to 1.33) 0.85
High diastolic BP 1.08 (0.80 to 1.46) 1.14 (0.82 to 1.58) 0.91 (0.71 to 1.16) 0.93 (0.71 to 1.22) 0.31
High LDLc 1.28 (1.11 to 1.47) 1.23 (1.05 to 1.43) 1.29 (1.08 to 1.54) 1.29 (1.03 to 1.54) 0.10
High triglycerides 1.36 (1.00 to 1.87) 1.42 (1.01 to 1.99) 1.96 (1.57 to 2.46) 1.97 (1.50 to 2.59) 0.99
Low HDLc 1.41 (1.23 to 1.62) 1.29 (1.12 to 1.49) 1.45 (1.30 to 1.62) 1.40 (1.25 to 1.57) 1.00
High glucose 1.09 (0.87 to 1.33) 1.06 (0.84 to 1.32) 1.18 (1.03 to 1.35) 1.14 (0.99 to 1.32) 0.003
High insulin 1.58 (1.32 to 1.88) 1.47 (1.20 to 1.80) 1.89 (1.64 to 2.18) 1.84 (1.56 to 2.17) <0.001
Fat mass
High systolic BP 1.26 (1.14 to 1.40) 1.24 (1.11 to 1.39) 1.20 (1.08 to 1.32) 1.20 (1.08 to 1.31) 0.78
High diastolic BP 1.09 (0.81 to 1.46) 1.14 (0.82 to 1.58) 0.92 (0.74 to 1.15) 1.06 (0.82 to 1.35) 0.10
High LDLc 1.24 (1.09 to 1.42) 1.19 (1.03 to 1.38) 1.33 (1.09 to 1.62) 1.31 (1.06 to 1.62) 0.32
High triglycerides 1.23 (0.90 to 1.68) 1.26 (0.91 to 1.76) 1.93 (1.53 to 2.44) 1.92 (1.45 to 2.54) 0.49
Low HDLc 1.35 (1.18 to 1.55) 1.23 (1.06 to 1.43) 1.41 (1.25 to 1.60) 1.36 (1.20 to 1.54) 1.00
High glucose 1.05 (0.85 to 1.30) 1.02 (0.82 to 1.27) 1.24 (1.08 to 1.42) 1.20 (1.03 to 1.40) 0.002
High insulin 1.58 (1.33 to 1.87) 1.48 (1.22 to 1.79) 1.99 (1.72 to 2.30) 1.95 (1.65 to 2.29) <0.001
BMI=body mass index; LDLc=low density lipoprotein cholesterol; HDLc=high density lipoprotein cholesterol.
*High systolic blood pressure ≥130 mm Hg; high diastolic blood pressure ≥85 mm Hg; high LDLc ≥2.75 mmol/l; high triglycerides ≥1.7 mmol/l; low
HDLc <1.03 mmol/l; high glucose ≥5.6 mmol/l; high insulin ≥16.95 IU/l.
†Adjusted for age, height, and height2.
‡As for model 1 plus adjusted for maternal age, parity, family social class, maternal education, paternal education, birth weight, gestational age,
maternal and paternal BMI, and puberty (additional adjustment for age at menarche in girls did not alter associations presented here for girls).
§Interaction test for association in fully adjusted model (model 2): tests null hypothesis that fully adjusted associations in girls and boys are same.
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were less likely to have had three or more previous
pregnancies, and weremore likely to have a university
degree, and both parents were less likely to smoke.
Differences in these family characteristics (asmeasured
here), however, could not explain the reduced cardio-
vascular risk in those who favourably altered their
adiposity profile between 9-12 and 15-16 years as all
results in table 4 are adjusted for these characteristics.
When we further adjusted the associations between
change in overweight/obese categories for baseline
BMI (or waist circumference or fat mass) as a continu-
ous variable and also for baseline systolic blood pres-
sure the results were somewhat attenuated compared
with those in table 4, but overall patterns were not
different. These adjustments did not explain the differ-
ences between those who changed from overweight/
obese at 9-12 to normal at 15-16 compared with those
who were overweight/obese at both ages. For exam-
ple, for girls the odds ratio for high concentration of
fasting insulin with these additional adjustments was
0.82 (0.41 to 1.65) in those who were overweight/
obese at age 9-12 and then normal at 15-16; 2.85
(1.67 to 4.87) in those who were normal at 9-12 and
overweight/obese at 15-16; and 1.85 (1.02 to 3.36) in
those who were overweight/obese at both ages com-
pared with girls who were normal weight at both
ages. The corresponding figures for boys were 1.99
(1.00 to 4.00), 4.08 (1.97 to 8.43), and 6.52 (3.56 to
11.81), respectively. When all of these analyses of
change were repeated with categories of overweight/
obese defined by thresholds of waist circumference or
fat mass they did not differ in their patterns, or substan-
tively in their magnitudes, to those presented here for
categories defined by BMI (results available from
authors on request).
Inmodels including only potential confounders (but
not any of the adiposity measures) between 1% (for
fasting low density lipoprotein cholesterol, triglycer-
ides, and glucose) and 2.5% (systolic blood pressure,
high density lipoprotein cholesterol, insulin) of the var-
iation in cardiovascular outcomes were explained.
Addition of BMI only to these models increased the
variation explained in the outcome to between 4%
(low density lipoprotein cholesterol, triglycerides, glu-
cose (in boys)) and 7% (systolic blood pressure and
insulin). Further addition of waist circumference or
Table 2 | Prospective associations between BMI, waist, and fat mass (assessed at age 9-12) and cardiovascular risk factor as
continuously measured outcomes at age 15-16 in all eligible participants with missing data imputed by multivariate
multiple imputation (n=5235). Figures are mean differences (null value 0) or ratios of geometric means (for triglycerides and
insulin, null value 1) of outcome per 1SD (z score) of exposure (95% confidence interval)
Exposure and
outcome
Girls (n=2747) Boys (n=2488) P value for sex
interaction‡Model 1* Model 2† Model 1* Model 2†
BMI
Systolic BP (mm Hg) 1.54 (1.12 to 1.96) 1.51 (1.07 to 1.98) 1.28 (0.86 to 1.71) 1.09 (0.67 to 1.52) 0.18
Diastolic BP (mm Hg) −0.09 (−0.42 to 0.25) −0.05 (−0.37 to 0.31) −0.15 (−0.53 to 0.23) −0.03 (−0.40 to 0.44) 0.94
LDLc (mmol/l) 0.06 (0.03 to 0.09) 0.04 (0.02 to 0.07) 0.06 (0.04 to 0.09) 0.07 (0.05 to 0.10) 0.10
HDLc (mmol/l) −0.04 (−0.06 to −0.02) −0.04 (−0.06 to −0.02) −0.05 (−0.07 to −0.03) −0.05 (−0.07 to −0.03) 0.49
Glucose (mmol/l) 0.00 (−0.03 to 0.03) 0.01 (−0.02 to 0.04) 0.07 (0.05 to 0.08) 0.06 (0.05 to 0.07) <0.001
Triglycerides§ 1.03 (1.00 to 1.05) 1.04 (1.01 to 1.05) 1.07 (1.04 to 1.08) 1.07 (1.04 to 1.08) 0.03
Insulin§ 1.09 (1.07 to 1.12) 1.08 (1.06 to 1.10) 1.22 (1.19 to 1.23) 1.20 (1.18 to 1.21) <0.001
Waist circumference
Systolic BP (mm Hg) 1.45 (0.98 to 1.92) 1.33 (0.82 to 1.84) 1.15 (0.66 to 1.62) 0.89 (0.41 to 1.38) 0.22
Diastolic BP (mm Hg) −0.24 (−0.61 to 0.12) −0.20 (−0.58 to 0.18) −0.48 (−0.89 to −0.07) −0.27 (−0.69 to 0.13) 0.81
LDLc (mmol/l) 0.07 (0.05 to 0.09) 0.05 (0.03 to 0.08) 0.09 (0.06 to 0.11) 0.08 (0.05 to 0.10) 0.10
HDLc (mmol/l) −0.05 (−0.07 to −0.03) −0.05 (−0.07 to −0.02) −0.06 (−0.08 to −0.03) −0.05 (−0.08 to −0.02) 0.99
Glucose (mmol/l) 0.00 (−0.03 to 0.03) 0.01 (−0.02 to 0.04) 0.06 (0.05 to 0.07) 0.05 (0.04 to 0.06) 0.008
Triglycerides 1.03 (1.00 to 1.05) 1.04 (1.01 to 1.06) 1.09 (1.07 to 1.12) 1.09 (1.07 to 1.12) 0.003
Insulin 1.09 (1.07 to 1.12) 1.08 (1.06 to 1.10) 1.24 (1.22 to 1.27) 1.22 (1.19 to 1.24) <0.001
Fat mass
Systolic BP (mm Hg) 1.65 (1.19 to 2.12) 1.58 (1.09 to 2.06) 1.20 (0.72 to 1.65) 0.92 (0.45 to 1.36) 0.10
Diastolic BP (mm Hg) 0.07 (−0.29 to 0.44) 0.15 (−0.24 to 0.53) −0.18 (−0.59 to 0.23) −0.10 (−0.50 to 0.30) 0.38
LDLc (mmol/l) 0.06 (0.03 to 0.08) 0.04 (0.02 to 0.07) 0.06 (0.03 to 0.09) 0.06 (0.03 to 0.09) 0.32
HDLc (mmol/l) −0.04 (−0.06 to −0.02) −0.03 (−0.05 to −0.01) −0.05 (−0.07 to −0.03) −0.04 (−0.06 to −0.02) 0.49
Glucose (mmol/l) 0.00 (−0.03 to 0.03) 0.00 (−0.03 to 0.03) 0.07 (0.05 to 0.08) 0.06 (0.05 to 0.07) <0.001
Triglycerides§ 1.02 (0.99 to 1.04) 1.02 (1.00 to 1.04) 1.07 (1.05 to 1.09) 1.07 (1.05 to 1.09) 0.002
Insulin§ 1.10 (1.08 to 1.12) 1.08 (1.06 to 1.10) 1.22 (1.19 to 1.24) 1.19 (1.17 to 1.21) <0.001
BMI=body mass index; LDLc=low density lipoprotein cholesterol; HDLc=high density lipoprotein cholesterol.
*Adjusted for age, height, and height2.
†As for model 1 plus adjusted for maternal age, parity, family social class, maternal education, paternal education, birth weight, gestational age,
maternal and paternal BMI, and puberty (additional adjustment for age at menarche in girls did not alter associations presented here for girls).
‡Interaction test for association in fully adjusted model (model 2): tests null hypothesis that fully adjusted association in girls and boys are
same.§Results are ratios of geometric means for each outcome per 1 SD greater exposure (BMI, waist, fat mass).
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fat mass did not increase the amount of variation in the
outcomes explained by the independent variables. In
models including just one of the threemeasurements of
adiposity there were no problems with variance infla-
tion (all variance inflation factors between 1.0 and 1.5).
Inmodelswith twoof themeasurements variance infla-
tion factors increased to between 8.0 and 10.5 andwith
all three in the model they were between 9.5 to 11.5,
suggesting potential problems with collinearity.
Whenwe repeated all analyses limiting the sample to
include participants with no missing data (tables K-O
on bmj.com), results did not differ substantially from
those presented here.
DISCUSSION
Main findings
Childhood BMI alone adequately identifies those who
will be at increased risk of adverse cardiovascular pro-
files in adolescence, and a direct assessment of fat mass
or a measure of central adiposity (waist circumference)
is notmore strongly associatedwith adverse outcomes.
Children who change from overweight to normal
weight improve their cardiovascular profiles
compared with those children who remain overweight
in childhood and adolescence.
All threemeasures of adiposity assessed in childhood
are prospectively associated with adverse cardio-
vascular risk factors in adolescents, with similar magni-
tudes of association. These associations are robust to
adjustment for a wide range of potential confounding
factors. The magnitude of associations between adipos-
ity in childhood and cardiovascular risk factors assessed
in adolescence are similar to equivalent associations
found in studies of middle aged adults,23 suggesting
that greater adiposity begins to adversely influence
cardiovascular risk factors even in childhood/adoles-
cence. BMI, waist circumference, and fat mass were all
strongly correlated with each other, and neither child-
hood waist circumference nor fat mass was more
strongly associated than BMI with cardiovascular risk
factors. The addition of fat mass or waist circumference
tomultivariablemodels including BMI did not increase
the amount of variation in cardiovascular outcomes
explained by the independent variables in models
withmore than one of these adipositymeasures, though
there was some evidence of collinearity.
Table 3 | Prospective associations of change in BMI, waist circumference, and fat mass between age 9-12 and age 15-16
with cardiovascular risk factor as binary outcomes assessed at age 15-16 in all eligible participants with missing data
imputed by multivariate multiple imputation (n=5235). Figures are odds ratios of outcome per 1SD (z-score) change of
exposure (95% confidence interval)
Exposure and outcome*
Girls (n=2747) Boys (n=2488) P value for sex
interaction§Model 1† Model 2‡ Model 1† Model 2‡
Change in BMI z score
High systolic BP 1.49 (1.28 to 1.73) 1.52 (1.30 to 1.78) 1.51 (1.31 to 1.73) 1.50 (1.30 to 1.73) 0.98
High diastolic BP 1.22 (0.81 to 1.85) 1.35 (0.86 to 2.12) 1.04 (0.75 to 1.46) 1.07 (0.76 to 1.51) 0.57
High LDLc 1.44 (1.19 to 1.74) 1.40 (1.14 to 1.71) 1.80 (1.38 to 2.34) 1.80 (1.38 to 2.34) 0.43
High triglycerides 1.94 (1.33 to 2.83) 2.23 (1.46 to 3.40) 2.90 (2.04 to 4.13) 3.11 (2.12 to 4.57) 0.27
Low HDLc 1.82 (1.49 to 2.23) 1.76 (1.42 to 2.19) 1.67 (1.36 to 2.05) 1.67 (1.34 to 2.05) 0.82
High glucose 1.06 (0.81 to 1.38) 1.03 (0.79 to 1.34) 1.39 (1.16 to 1.67) 1.38 (1.15 to 1.66) 0.06
High insulin 2.24 (1.81 to 2.79) 2.27 (1.79 to 2.87) 3.63 (2.77 to 4.76) 3.74 (2.83 to 4.96) 0.01
Change in waist circumference z score
High systolic BP 1.32 (1.15 to 1.52) 1.35 (1.17 to 1.56) 1.34 (1.17 to 1.54) 1.34 (1.17 to 1.54) 0.99
High diastolic BP 1.09 (0.76 to 1.57) 1.17 (0.79 to 1.74) 1.13 (0.83 to 1.54) 1.17 (0.85 to 160) 0.99
High LDLc 1.36 (1.13 to 1.62) 1.31 (1.09 to 1.59) 1.61 (1.24 to 2.10) 1.63 (1.28 to 2.09) 0.46
High triglycerides 1.90 (1.27 to 2.83) 2.08 (1.34 to 3.21) 2.44 (1.63 to 3.66) 2.62 (1.83 to 3.76) 0.43
Low HDLc 1.70 (1.39 to 2.08) 1.67 (1.36 to 2.04) 1.51 (1.23 to 1.86) 1.51 (1.23 to 1.86) 0.69
High glucose 1.04 (0.81 to 1.33) 1.01 (0.79 to 1.30) 1.36 (1.16 to 1.61) 1.35 (1.14 to 1.60) 0.05
High insulin 1.86 (1.51 to 2.28) 1.85 (1.50 to 2.80) 3.27 (2.48 to 4.30) 3.44 (2.67 to 4.43) 0.004
Change in fat mass z score
High systolic BP 1.44 (1.25 to 1.66) 1.49 (1.28 to 1.74) 1.24 (1.09 to 1.41) 1.24 (1.09 to 1.42) 0.68
High diastolic BP 1.21 (0.82 to 1.79) 1.37 (0.90 to 2.09) 0.81 (0.58 to 1.13) 0.83 (0.59 to 1.16) 0.49
High LDLc 1.45 (1.20 to 1.75) 1.39 (1.14 to 1.71) 1.78 (1.44 to 2.22) 1.79 (1.43 to 2.24) 0.61
High triglycerides 2.11 (1.45 to 3.07) 2.43 (1.58 to 3.72) 2.39 (1.76 to 3.25) 2.46 (1.76 to 3.45) 0.97
Low HDLc 1.82 (1.50 to 2.21) 1.76 (1.42 to 2.18) 1.46 (1.22 to 1.75) 1.44 (1.21 to 1.72) 0.84
High glucose 1.16 (0.88 to 1.51) 1.12 (0.85 to 1.49) 1.49 (1.24 to 1.78) 1.48 (1.24 to 1.77) 0.09
High insulin 2.28 (1.84 to 2.81) 2.33 (1.85 to 2.94) 3.37 (2.61 to 4.36) 3.51 (2.69 to 4.57) 0.03
BMI=body mass index; LDLc=low density lipoprotein cholesterol; HDLc=high density lipoprotein cholesterol.
*High systolic blood pressure ≥130 mm Hg; high diastolic blood pressure ≥85 mm Hg; high LDLc ≥2.75 mmol/l; high triglycerides ≥1.7 mmol/l; low
HDLc <1.03 mmol/l; high glucose ≥5.6 mmol/l; high insulin ≥16.95 IU/l.
†Adjusted for age, height, height2, BMI, waist circumference, or fat mass (as appropriate for their respective change exposure) at baseline.
‡As for model 1 plus adjusted for maternal age, parity, family social class, maternal education, paternal education, birth weight, gestational age,
maternal and paternal BMI, and puberty (additional adjustment for age at menarche in girls did not alter associations presented here for girls).
§Interaction test for association in fully adjusted model (model 2): tests null hypothesis that fully adjusted association in girls and boys are same.
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Girls who were overweight/obese at age 9-12 but
were normal weight by 15-16 had similar odds of
adverse levels of risk factors to those who were normal
weight at both ages. In boys odds of higher systolic
blood pressure and higher concentrations of triglycer-
ides and insulin and lower concentrations of high den-
sity lipoprotein cholesterol remained higher in this
group compared with those who were normal weight
at both ages but were lower than in those who
remained overweight/obese at both ages or who were
normal at age 9-12 and then overweight/obese at age
15-16. Thus, in both sexes changing from overweight/
obese at age 9-12 to normal weight at age 15-16 was
associated with better risk profiles than remaining
overweight/obese from childhood through to adoles-
cence. Those who made this change to normal weight
had on average lower mean levels of BMI, waist cir-
cumference, and fat mass at age 9-12 than those who
remained overweight/obese at both ages and also had
somewhat lower systolic blood pressure. When we
adjusted for these baseline characteristics, however,
the improvements in those moving to the normal cate-
gory remained.
Comparisons with other studies and implications
Fewprevious studies have examined change in adipos-
ity between childhood and adolescence/early adult-
hood in relation to cardiovascular risk factors. Of
those that have, all suggest that those whose adiposity
decreases (relative to age and sex standards) have
improved cardiovascular risk profiles, whereas those
whose levels increase tend to have worse profiles.4 5 24
Contrary to concerns about BMI not being a suitable
measurement of adiposity in childhood,13 14 we found
no difference in themagnitudes of prospective associa-
tions between BMI, waist circumference, or fat mass in
thewhole cohort or in analyses restricted to those in the
normal BMI range, suggesting that with respect to
identifying those with more adverse cardiovascular
risk profiles BMI is just as suitable as waist
circumference or fatmass in children. This work builds
on a previous publication from the Avon Longitudinal
Study inwhich the cross sectional associations between
blood pressure in childhood and BMI and fat mass
determined by dual energy x ray absorptiometry
were compared and found to be similar.25 That study
did not consider waist circumference, nor outcomes
other than blood pressure, and the study was cross sec-
tional. It also builds on a cross sectional study of data at
age 9-10, which found similar magnitudes of associa-
tion between BMI, waist, and fat mass and cardio-
vascular risk factors.26 That study was cross sectional
and assessed non-fasting lipids and did not have infor-
mation on glucose or insulin. Waist circumference
might be less reliably measured than BMI or fat mass
andwere it possible tomeasure itmore reliably itmight
be associated more strongly with cardiovascular risk
factors. Recent evidence suggests that where waist cir-
cumference is measured in overweight children affects
its relation with cardiovascular risk factors, with the
mid-point between the ribs and iliac crest (as used
here) or the narrowest circumference being more
strongly associatedwith risk factors than the circumfer-
ence at the level of the umbilicus or the iliac crest.27
Thus, it is unlikely that our results are affected bymea-
suring waist circumference at an inappropriate site.
Marked central distribution of adiposity might not
occur until after puberty, and it will be worth repeating
our analyses as these children go into adulthood.
Recent findings in adults, however, suggest that BMI
and waist circumference are similarly associated with
cardiovascular disease events,28 suggesting that general
adiposity is as useful as its distribution for identifying
those at risk or that better measurements (that is, better
than waist circumference) are required for identifying
detrimental central adiposity, in particular visceral
adiposity.
One implication of our findings is that BMI in chil-
dren is suitable for identifying those at risk of future
adverse cardiovascular risk profiles in clinical practice
Table 4 | Multivariable associations of change in BMI category between age 9-12 and 15-16 years with cardiovascular risk factors as binary outcomes in all
eligible participants with missing data multiply imputed
BMI category at age 9-12
and age 15-16 % (SE)*
Mean (SE) BMI
at age 15
Odds ratio† (95% CI)
High SBP
(≥130 mm Hg)
High LDLc
(≥2.75 mmol/l)
High triglycerides
(≥1.7 mmol/l)
Low HDLc
(<1.03 mmol/l)
High glucose
(≥5.6 mmol/l)
High insulin
(≥16.95 IU/l)
Girls (n=2747)
Normal at both 70.7 (0.9) 20.2 (0.05) Reference Reference Reference Reference Reference Reference
Overweight-obese/normal 11.1 (0.6) 22.9 (0.15) 1.06 (0.77 to1.47) 1.04 (0.67 to1.61) 1.81 (0.72 to 4.52) 1.01 (0.65 to1.58) 0.83 (0.47 to1.47) 0.97 (0.55 to 1.73)
Normal/overweight-obese 4.8 (0.4) 25.5 (0.11) 1.61 (1.04 to2.47) 1.55 (0.91 to2.66) 4.41 (1.73 to 11.22) 2.25 (1.34 to3.79) 0.86 (0.36 to2.06) 3.37 (1.20 to 1.42)
Overweight-obese at both 13.4 (0.6) 28.1 (0.18) 1.74 (1.29 to2.33) 1.59 (1.07 to2.36) 2.88 (1.20 to 6.89) 2.30 (1.50 to3.54) 1.05 (0.55 to1.99) 2.87 (1.77 to 4.66)
Boys (n=2488)
Normal at both 74.6 (0.8) 19.6 (0.04) Reference Reference Reference Reference Reference Reference
Overweight-obese/normal 9.1 (0.6) 22.5 (0.15) 1.60 (1.20 to2.14) 1.37 (0.75 to2.49) 3.35 (1.42 to 7.91) 1.50 (1.00 to2.11) 1.18 (0.77 to1.79) 2.43 (1.33 to 4.45)
Normal/overweight-obese 4.1 (0.4) 24.5 (0.10) 1.58 (1.03 to2.41) 2.35 (1.14 to4.85) 5.38 (1.97 to 14.65) 2.34 (1.43 to3.83) 1.25 (0.71 to2.20) 4.35 (2.13 to 8.91)
Overweight-obese at both 12.2 (0.7) 27.3 (0.18) 1.92 (1.49 to2.47) 2.29 (1.40 to3.77) 8.04 (4.06 to 15.93) 2.81 (2.00 to3.96) 1.81 (1.24 to2.65) 8.48(5.47 to13.15)
BMI=body mass index; LDLc=low density lipoprotein cholesterol; HDLc=high density lipoprotein cholesterol.
*Percentage (%) and standard error (SE) in each category across the datasets provides as results from multivariate multiple imputation analyses are based on combining results across 20
databases so exact numbers in each category cannot be provided.
†Adjusted for age, height, height2, maternal age, parity, family social class, maternal education, paternal education, birth weight, gestational age, maternal and paternal BMI, and puberty
(additional adjustment for age at menarche in girls did not alter associations).
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and public health surveillance and that in these settings
use of more sophisticated measurements of fat mass
and adiposity distribution are unlikely to be needed.
In research projects, particularly in large epidemiologi-
cal studies where the addition of more sophisticated
measurements might increase costs markedly, these
results could suggest that fat mass determined by dual
energy x ray absorptiometry and waist circumference
are unnecessary. We would argue against this for sev-
eral reasons. Firstly,while our results show similar asso-
ciations with cardiovascular risk factors we have
previously reported differences with determinants or
risk factors for greater adiposity in this cohort. For
example, we found a stronger association between
socioeconomic position and fat mass than with BMI29
and that the FTO genotype was specifically associated
with fat mass.30 Secondly, it would be valuable to see if
our findings can be replicated in other cohort studies,
including those with different ethnic groups in whom
sensitivity tometabolic effects of adiposity canbemuch
greater. Thirdly, as noted above, as the participants in
this cohort age the correlation between the three mea-
surements of adiposity might reduce and differences in
how they relate to risk factors might emerge.
It is unclear why we found no prospective associa-
tion between adiposity and diastolic blood pressure.
Other early life risk factors, including birth weight,
gestational age, and socioeconomic position, are asso-
ciated with systolic blood pressure but not with (or
moreweaklywith) diastolic bloodpressure.31Our find-
ing that associations of adiposity measured in child-
hood (9-12 years) with cardiovascular risk factors in
adolescence (15-16) were stronger in boys than girls
for fasting insulin, glucose, and triglyceride concentra-
tions has not been previously reported, and in adults
adiposity is similarly associated with cardiovascular
disease events and risk factors in women and men.23
A small study (n=193-350 for different analyses) with
detailed measurements including repeat assessment
with the euglycaemic clamp, assessed on three occa-
sions from age 11 to 19, found that insulin resistance
and triglyceride concentrations increased in boys and
high density lipoprotein cholesterol concentrations
decreased as theymoved from childhood through ado-
lescence, despite a decrease in body fat (and increase in
lean mass) over this time period.32 In girls they found
the opposite (that is, an increase in body fatness but a
decrease in insulin resistance as theywent through ado-
lescence). Thus, our findings might have been influ-
enced by sex differences occurring during the
transition through puberty and might be related to
where fat is placed—that is, preferentially more subcu-
taneous and “safe” weight gain in girls than in boys.32
The linear associations found across the whole dis-
tributions of childhood adiposity suggest that there is
no threshold effect of increase in cardiovascular risk at
high levels of adiposity in children. This finding high-
lights the importance of prevention strategies aimed at
shifting the population distribution of childhood adip-
osity downwards. This noted, some children whowere
overweight/obese age 9-12 seemed to have normalised
their weight category status without formal inter-
vention that we are aware of and in doing so improved
their cardiovascular profile. The children in this group
wereon average somewhat less adipose than thosewho
did not move down to the normal weight group but
adjustment for mean BMI (or waist circumference or
fat mass) at baseline did not markedly alter the associa-
tions between change in weight category status and
cardiovascular risk factors.
Study strengths and limitations
We examined associations prospectively, compared
three different measurements of adiposity and changes
in these over time, and adjusted for a wide range of
potential confounding factors. Consistent with all other
birth cohorts and prospective cohorts in general there
has been loss to follow-up, with those who continue to
attend regular follow-up clinics being more likely to be
from higher socioeconomic backgrounds.15 We cannot,
however, think of any reason why adiposity should be
differently associated with cardiovascular risk factors in
those who were lost to follow-up. Our multivariate mul-
tiple imputation analysis suggests that there are nomajor
problems with selection bias between those with no
missing data (including on fasting bloods) and the
whole eligible cohortwho attended the follow-up clinics.
Our measurements of adiposity were obtained when
nearly all the children will have been prepubertal.
Because we preferentially used measurements from the
9-10 clinic, and used those from the 11-12 clinic when
theseweremissing, 75%of participants were aged under
10 at the time of baseline assessment and 82.5% were
Tanner stage I or II by parental report with just 2.5% of
the girls having gone through menarche. As discussed
above, it is possible that measurements of central adip-
osity afterpuberty relatemore strongly to cardiovascular
risk factors. The participants in this study are predomi-
nantly of European origin; all were born and most were
brought up in theUK.Wecannot assume that these find-
ings would apply to other ethnic groups or to children
brought up in difference environments.
Conclusion
In summary, our results show that greater adiposity at
age 9-12 is associated with adverse cardiovascular risk
factors at age 15-16 and that these associations are con-
tinuous across the full range of general population
levels of childhood adiposity and robust to adjustment
for a wide range of potential confounding factors. BMI
in childhood is prospectively associated with cardio-
vascular risk factors with the similar magnitudes of
association as fatmass orwaist circumference. It is reas-
suring that our results suggest that change to normal
weight by adolescence among those who are over-
weight/obese in childhood is associated with better
cardiovascular risk profiles than in those who remain
overweight.Our findings highlight the need to shift the
whole distribution of adiposity in children downwards
and to develop interventions that safely and effectively
reduce weight and improve cardiovascular risk factors
in overweight/obese children.
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